title: Many unknowns in low-risk prostate cancer treatment. Ongoing studies and biomarker research may shed light on best approach.
authors.forename: Carrie
authors.initials: C
authors.lastname: Printz
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis*; D055088:Early Detection of Cancer; D006801:Humans; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D017430:Prostate-Specific Antigen / Q000032:analysis; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000628:therapy*; D012106:Research; D012306:Risk
chemical_list: D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen